Pew Applauds U.S. House Passage of FDA User Fee Legislation

Contact: Linda Paris, 202.540.6354,

Washington, DC - 06/21/2012 - The U.S. House of Representatives Wednesday passed the Food and Drug Administration Safety and Innovation Act (S. 3187), a bill to support the FDA’s drug and device reviews.

“We commend the House for passing the bipartisan Food and Drug Administration Safety and Innovation Act," said Allan Coukell, director of medical programs at the Pew Health Group. "This legislation will help deliver safe, effective and innovative medical products to patients. We also commend Energy and Commerce Committee Chairman Fred Upton (R-MI), Ranking Member Henry Waxman (D-CA), Health Subcommittee Chairman Joe Pitts (R-PA), and Ranking Member Frank Pallone (D-PA) for their leadership throughout this process. We look forward to its passage through the U.S. Senate.” 

(All Fields are required)